Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 3 (2006), Issue 6 (June)

1. Neuropsychology and neuropharmacology of P3a and P3b.
   Int J Psychophysiol, 60(2): 172-85. [Abstract] [Full-text]
2. Secular trends in legal and illegal substance use among 16 to 20 year old adolescents in Switzerland.
   Swiss Med Wkly, 136(19): 318-26. [Abstract] [Full-text]
3. Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder.
   Pediatrics, 117(6): 2030-9. [Abstract] [Full-text]
4. Combining psychometric and biometric measures of substance use.
   Drug Alcohol Depend, 83(2): 95-103. [Abstract] [Full-text]
5. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
   Drug Alcohol Depend, 83(2): 181-4. [Abstract] [Full-text]
6. Changes in maternal marital status are associated with young adults' cannabis use: evidence from a 21-year follow-up of a birth cohort.
   Int J Epidemiol, 35(3): 673-9. [Abstract] [Full-text]
7. Illicit psychoactive substance use, abuse and dependence in a population-based sample of Norwegian twins.
   Psychol Med, 36(7): 955-62. [Abstract] [Full-text]
8. Analysis of choline and atropine in hairy root cultures of Cannabis sativa L. by capillary electrophoresis-electrospray mass spectrometry.
   Electrophoresis, 27(11): 2208-15. [Abstract] [Full-text]
9. Incidence and correlates of unwanted sex in relationships of middle and late adolescent women.
   Arch Pediatr Adolesc Med, 160(6): 591-5. [Abstract] [Full-text]
10. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
    Drug Alcohol Rev, 25(3): 269-76. [Abstract] [Full-text]
11. Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes.
    Drug Alcohol Rev, 25(3): 249-58. [Abstract] [Full-text]
12. Comparison of trends in gastroschisis and prenatal illicit drug use rates.
    J Toxicol Environ Health A, 69(13): 1253-9. [Abstract] [Full-text]
13. Reasons for cannabis use in psychosis.
    Aust N Z J Psychiatry, 40(6): 570-4. [Abstract] [Full-text]
14. Application of a computational decision model to examine acute drug effects on human risk taking.
    Exp Clin Psychopharmacol, 14(2): 254-64. [Abstract] [Full-text]
15. Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans.
    J Psychopharmacol, 20(4): 471-84. [Abstract] [Full-text]
16. Dependence symptoms in young cannabis users? A prospective epidemiological study.
    J Psychiatr Res, 40(5): 394-403. [Abstract] [Full-text]
17. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
    Nat Med, 12(6): 671-6. [Abstract] [Full-text]
18. Social anxiety and problematic cannabis use: evaluating the moderating role of stress reactivity and perceived coping.
    Behav Res Ther, 44(7): 1007-15. [Abstract] [Full-text]
19. Anxiety sensitivity interacts with marijuana use in the prediction of anxiety symptoms and panic-related catastrophic thinking among daily tobacco users.
    Behav Res Ther, 44(7): 907-24. [Abstract] [Full-text]
20. Exploring the link between substance abuse and abortion: the roles of unconventionality and unplanned pregnancy.
    Perspect Sex Reprod Health, 38(2): 66-75. [Abstract] [Full-text]
21. Consequences of youth tobacco use: a review of prospective behavioural studies.
    Addiction, 101(7): 948-58. [Abstract] [Full-text]
22. Drug abuse in women with eating disorders.
    Int J Eat Disord, 39(5): 364-8. [Abstract] [Full-text]
23. Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs.
    J Neurosci, 26(24): 6458-68. [Abstract] [Full-text]
24. "Islands of Risk": subgroups of adolescents at risk for HIV.
    J Pediatr Psychol, 31(6): 619-29. [Abstract] [Full-text]
25. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Neuropsychopharmacology, 31(7): 1562-73. [Abstract] [Full-text]
26. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence.
    Am J Med Genet B Neuropsychiatr Genet, 141(5): 499-503. [Abstract] [Full-text]
27. The changing risk profile of the American adolescent smoker: implications for prevention programs and tobacco interventions.
    J Adolesc Health, 39(1): 120.e1-10. [Abstract] [Full-text]
28. Who does the hat fit? Teenager heterogeneity and the effectiveness of information policies in preventing cannabis use and heavy drinking.
    Health Econ, 15(7): 697-718. [Abstract] [Full-text]
29. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Mol Pharmacol, 70(1): 41-50. [Abstract] [Full-text]
30. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
    J Pharmacol Exp Ther, 318(1): 304-11. [Abstract] [Full-text]
31. Mediators of the stress-substance-use relationship in urban male adolescents.
    Prev Sci, 7(2): 113-26. [Abstract] [Full-text]
32. Cannabis and neurodevelopment: implications for psychiatric disorders.
    Hum Psychopharmacol, 21(4): 245-54. [Abstract] [Full-text]
33. Patterns of simultaneous polysubstance use in drug using university students.
    Hum Psychopharmacol, 21(4): 255-63. [Abstract] [Full-text]
34. Determination of the prevalence of drug misuse by meconium analysis.
    Arch Dis Child Fetal Neonatal Ed, 91(4): F291-2. [Abstract] [Full-text]
35. Major depression, alcohol and drug use disorders do not appear to account for the sexually transmitted disease and HIV epidemics in the southern United States.
    Sex Transm Dis, 33(7): S70-7. [Abstract] [Full-text]
36. A content analysis of personal strivings: associations with substance use.
    Addict Behav, 31(7): 1224-30. [Abstract] [Full-text]
37. Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening.
    Addict Behav, 31(7): 1252-8. [Abstract] [Full-text]
38. Substance use and multiple victimisation among adolescents in South Africa.
    Addict Behav, 31(7): 1163-76. [Abstract] [Full-text]
39. A latent class analysis of underage problem drinking: evidence from a community sample of 16-20 year olds.
    Drug Alcohol Depend, 83(3): 199-209. [Abstract] [Full-text]
40. Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment.
    Biol Psychiatry, 60(1): 77-9. [Abstract] [Full-text]
41. Drug use and kidney donation: what are high-risk behaviors today?
    Transplant Proc, 38(5): 1221-3. [Abstract] [Full-text]
42. Drug use, drug severity, and help-seeking behaviors of lesbian and bisexual women.
    J Womens Health (Larchmt), 15(5): 556-68. [Abstract] [Full-text]
43. Cannabis and sport.
    Br J Sports Med, 40: i13-5. [Abstract] [Full-text]
44. Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors.
    Addict Biol, 11(2): 131-44. [Abstract] [Full-text]
45. Relationship between adolescent marijuana use and young adult illicit drug use.
    Behav Genet, 36(4): 498-506. [Abstract] [Full-text]
46. Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: general or specific?
    Behav Genet, 36(4): 603-15. [Abstract] [Full-text]
47. Extensions to the modeling of initiation and progression: applications to substance use and abuse.
    Behav Genet, 36(4): 507-24. [Abstract] [Full-text]
48. Clustering of smoking, alcohol drinking and cannabis use in adolescents in a rapidly developing country.
    BMC Public Health, 6(1): 169. [Abstract] [Full-text]
49. Correlates of extracurricular sport participation among Swiss adolescents.
    Eur J Pediatr, 165(8): 546-55. [Abstract] [Full-text]
50. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia.
    Exp Brain Res, 172(4): 556-60. [Abstract] [Full-text]
51. History of cannabis as a medicine: a review.
    Rev Bras Psiquiatr, 28(2): 153-7. [Abstract] [Full-text]
52. Teenage pregnancy: use of drugs in the third trimester and prevalence of psychiatric disorders.
    Rev Bras Psiquiatr, 28(2): 122-5. [Abstract] [Full-text]
53. Cannabinoids biology: the search for new therapeutic targets.
    Mol Interv, 6(3): 149-61. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.